Chemical Biology meets Drug Discovery 2026
WuXi AppTec is pleased to participate in Chemical Biology Meets Drug Discovery 2026, taking place September 14–15, 2026, in Cambridge, United Kingdom. The meeting brings together researchers from academia and industry to explore how chemical biology can reveal disease mechanisms, validate therapeutic targets, and enable new drug discovery strategies.
Translating insights from chemical biology into viable therapeutic candidates requires close integration between target biology, assay development, compound design, and experimental validation. WuXi AppTec supports this process through multidisciplinary capabilities spanning chemical biology, medicinal chemistry, biology, DMPK, pharmacology, and structural sciences. Our teams help partners investigate target function, validate novel mechanisms, identify suitable chemical starting points, and progress promising compounds through hit-to-lead and lead optimization.
Our integrated platform supports a range of discovery approaches, including target validation, assay development, covalent inhibitor discovery, targeted protein degradation, peptide discovery, and mechanism-of-action studies. By combining these capabilities within a coordinated research program, we help partners address challenging targets, generate robust supporting data, and advance high-quality candidates toward selection.
We look forward to connecting with the chemical biology and drug discovery community in Cambridge and discussing how WuXi AppTec can support your next research program.
To schedule a dedicated meeting with our team, please fill out the form on the right.
Resource Links
WuXi AppTec Biology Services
Resource Type: Brochure
Research Chemistry Services
Resource Type: Brochure
